Giovanna Masci

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Marco Colleoni, Andrea Rocca, Maria Teresa Sandri et al. · Annals of Oncology · 2002 · 500 citations · Full text

Metastatic Breast Cancer, Oncology, Antitumor Activity +9

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Leticia De Mattos‐Arruda, Giulia Bottai, Paolo Nucíforo et al. · Oncotarget · 2015 · 150 citations · Full text

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

Marta Pestrin, Silvia Bessi, Fabio Puglisi et al. · Breast Cancer Research and Treatment · 2012 · 109 citations

Breast Oncology, Single-agent Lapatinib, Medicine +9

Minidose Warfarin Prophylaxis for Catheter-Associated Thrombosis in Cancer Patients: Can It Be Safely Associated With Fluorouracil-Based Chemotherapy?

Giovanna Masci, Massimo Magagnoli, Paolo Andrea Zucali et al. · Journal of Clinical Oncology · 2003 · 101 citations

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments

Marta Scorsetti, Filippo Alongi, Antonella Fogliata et al. · Radiation Oncology · 2012 · 92 citations · Full text